Lili Mao - Concepedia

Author

Lili Mao

Peking University ORCID

Also Known As

A. Mann, B. Mansoulie, D. C. Mankad, L. L. Mao, L. Mao, Leiyan Mao, Li-Li Mao, Li-li Mao, Lijuan Mao, Lili Mao

Publications

511

Citations

H-Index

Concepts

All Affiliations

Peking University Peking University Cancer Hospital Peking University First Hospital Nanjing Drum Tower Hospital Chinese Academy of Medical Sciences & Peking Union Medical College

About

Lili Mao is an author at Peking University specializing in oncology, urology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	189
2	Immunology	3	3	61
3	Business	1	1	25
4	Engineering	1	1	25
5	Logistics	1	1	25

Lili Mao

Publications

361

Citations

H-Index

Page 1

	Year	Citations
The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study Jia Zheng, Xinhua Xiao, Qian Zhang, Frontiers in Physiology	2017	57
Study RC48-C014: Preliminary results of RC48-ADC combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma. Li Zhou, Huayan Xu, Siming Li, Journal of Clinical Oncology PharmacotherapyImmunotherapeuticsMetronomic ChemotherapyTumor BiologyOncology	2022	41
A phase II study of RC48-ADC in HER2-negative patients with locally advanced or metastatic urothelial carcinoma. Huayan Xu, Xinan Sheng, Li Zhou, Journal of Clinical Oncology UrologyMetastatic Urothelial CarcinomaVisceral MetastasisGenitourinary CancerMedicine	2022	37
A phase II study of RC48-ADC in HER2-negative patients with locally advanced or metastatic urothelial carcinoma. Huayan Xu, Xinan Sheng, Xieqiao Yan, Journal of Clinical Oncology Rc48-adc TreatmentUrologyMetastatic Urothelial CarcinomaGenitourinary CancerMedicine	2020	35
Titanium-interlayer mediated hydroxyapatite coating on polyetheretherketone: a prospective study in patients with single-level cervical degenerative disc disease Ce Zhu, Miaomiao He, Lili Mao, Journal of Translational Medicine	2021	31
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population Li Zhou, Zhiting Shao, Yiqiang Liu, The Oncologist	2023	26
An improved scatter search algorithm for the corridor allocation problem considering corridor width Zeqiang Zhang, Lili Mao, Chao Guan, Soft Computing Mathematical ProgrammingTransport Network AnalysisFacility PlanningEngineeringRoute Planning	2019	25
Preliminary results of a phase Ib/II combination study of RC48-ADC, a novel humanized anti-HER2 antibody-drug conjugate (ADC) with toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) in patients with locally advanced or metastatic urothelial carcinoma. Xinan Sheng, Li Zhou, Zhisong He, Journal of Clinical Oncology ImmunologyPathologyMetronomic ChemotherapyOncologyGenitourinary Cancer	2022	25
Disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate (ADC), combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma: An open-label phase 1b/2 study. Xinan Sheng, Li Zhou, Kaiwei Yang, Journal of Clinical Oncology UrologyOpen-label Phase 1B/2Genitourinary CancerMedicineImmunology	2023	23
Telmisartan improves kidney function through inhibition of the oxidative phosphorylation pathway in diabetic rats Qian Zhang, Xinhua Xiao, Ming Li, Journal of Molecular Endocrinology	2012	22

Page 1